Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_1191 |
| Primary information | |
|---|---|
| B3PDB ID | b3pdb_1191 |
| Peptide Name | Gly-Pro |
| PEPTIDE SEQUENCE (1-letter) | GP |
| PEPTIDE SEQUENCE (3-letter) | Gly-Pro |
| N-terminal modification | NA |
| C-terminal modification | NA |
| Chemical modification | NA |
| Peptide Length | 2 |
| Conformation | Linear |
| Peptide Nature | NA |
| Source/Origin of peptide | Chemically synthesized |
| SMILES | NA |
| Cell Line | NA |
| In vitro CONCENTRATION | NA |
| In vitro METHOD | NA |
| In vitro RESULT | NA |
| ANIMAL MODEL | NA |
| In vivo CONCENTRATION | NA |
| In vivo MODE OF DELIVERY | in situ brain perfusion |
| In vivo METHOD | NA |
| In vivo RESULT | NA |
| ACTION | NA |
| TRANSPORT TYPE | Permeability |
| SUBCELLULAR LOCALISATION | NA |
| COMBINATION | NA |
| PHYSICAL CONDITION | NA |
| RESPONSE | Unidirectional flux rate constant |
| RESULT | 0.00349 mL/(g x min) |
| LABEL | NA |
| PMID | 30962462 |